These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 37682923)
1. Executive compensation controls and corporate cash holdings. Wang P; Zhang X; Wang T; Wan Z PLoS One; 2023; 18(9):e0285387. PubMed ID: 37682923 [TBL] [Abstract][Full Text] [Related]
2. Green credit policy and corporate excess cash holdings. Ning J; Wang G; Xiong F; Yin S PLoS One; 2024; 19(1):e0294079. PubMed ID: 38227573 [TBL] [Abstract][Full Text] [Related]
3. State ownership, information asymmetry and cash holding: Impact of COVID-19 on Chinese-listed firms. Yu D; Soh W; Noordin BAA; Yahya MH; Latif B Front Psychol; 2022; 13():1052979. PubMed ID: 36524178 [TBL] [Abstract][Full Text] [Related]
4. The COVID-19 outbreak and corporate cash-holding levels: Evidence from China. Zhou D; Zhou H; Bai M; Qin Y Front Psychol; 2022; 13():942210. PubMed ID: 36324775 [TBL] [Abstract][Full Text] [Related]
5. Firms' COVID-19 Pandemic Exposure and Corporate Cash Policy: Evidence from China. He Z; Suardi S; Wang K; Zhao Y Econ Model; 2022 Nov; 116():105999. PubMed ID: 36032988 [TBL] [Abstract][Full Text] [Related]
6. Country risk, global uncertainty, and firms' cash holdings: Do the role of law, culture, and financial market development matter? Athari SA; Cho Teneng R; Çetinkaya B; Bahreini M Heliyon; 2024 Mar; 10(5):e26266. PubMed ID: 38463892 [TBL] [Abstract][Full Text] [Related]
7. How does the data element-driven industry affect corporate cash holdings? Evidence from Chinese listed companies. Xiang Y; Xu M Heliyon; 2024 Jun; 10(12):e32737. PubMed ID: 38952370 [TBL] [Abstract][Full Text] [Related]
8. How does red culture affect corporates' cash holdings? Evidence from China. Li Z; Chen X; Yang B Heliyon; 2023 Apr; 9(4):e15435. PubMed ID: 37123901 [TBL] [Abstract][Full Text] [Related]
9. Fund holdings and real earnings management: An empirical analysis of the Chinese A-share market. Lian L; Zhao D; Dong Q Heliyon; 2024 Aug; 10(16):e36194. PubMed ID: 39224327 [TBL] [Abstract][Full Text] [Related]
10. The role of labor in cash holdings: Evidence from the supply-side impact of COVID-19. Bae J; Kang J Econ Lett; 2023 Mar; 224():111034. PubMed ID: 36817848 [TBL] [Abstract][Full Text] [Related]
11. Corporate payout, cash holdings, and the COVID-19 crisis: Evidence from the G-7 countries. Ntantamis C; Zhou J Financ Res Lett; 2022 Dec; 50():103275. PubMed ID: 36034341 [TBL] [Abstract][Full Text] [Related]
12. The impacts of economic policy uncertainty on firm cash holding in China. Chen X; Li J; Tang D; Shang L; Boamah V; Xu J; Deng Z PLoS One; 2023; 18(11):e0293306. PubMed ID: 37992087 [TBL] [Abstract][Full Text] [Related]
13. Air Pollution and Corporate Green Financial Constraints: Evidence from China's Listed Companies. Shen Y; Lyu M; Zhu J Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429753 [TBL] [Abstract][Full Text] [Related]
14. Financial performance of China's listed firms in presence of coronavirus: Evidence from corporate culture and corporate social responsibility. Zheng F; Zhao Z; Sun Y; Khan YA Curr Psychol; 2023; 42(11):8897-8918. PubMed ID: 34400856 [TBL] [Abstract][Full Text] [Related]
15. Corporate Competing Culture and Environmental Investment. Tian J; Cao W; Cheng Q; Huang Y; Hu S Front Psychol; 2021; 12():774173. PubMed ID: 35126237 [TBL] [Abstract][Full Text] [Related]
16. Soft information monitoring along the supply chain: Customer geographic proximity and firms' ESG performance. Cao L; Lau WY; Shaharuddin SS J Environ Manage; 2024 Oct; 369():122302. PubMed ID: 39226815 [TBL] [Abstract][Full Text] [Related]
17. Do corporate anti-bribery and corruption commitments enhance environmental management performance? The moderating role of corporate social responsibility accountability and executive compensation governance. Sarhan AA; Gerged AM J Environ Manage; 2023 Sep; 341():118063. PubMed ID: 37146491 [TBL] [Abstract][Full Text] [Related]
18. Is cash the panacea of the COVID-19 pandemic: Evidence from corporate performance. Zheng M Financ Res Lett; 2022 Mar; 45():102151. PubMed ID: 35221815 [TBL] [Abstract][Full Text] [Related]
19. COVID-19 impact on firm investment-Evidence from Chinese publicly listed firms. Jiang J; Hou J; Wang C; Liu H J Asian Econ; 2021 Aug; 75():101320. PubMed ID: 36567767 [TBL] [Abstract][Full Text] [Related]
20. How R&D intensive firms react to the COVID-19 pandemic: Evidence from a quasi-natural experiment. Pham THL; Nguyen DHT; Chu VT; Nguyen KD; Pham BT Heliyon; 2023 Sep; 9(9):e19329. PubMed ID: 37662736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]